U.S. Pharmaceuticals & Biotech Leverage Leaders

Stevanato Group

Market Cap: US$5.6b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

ADMA Biologics

Market Cap: US$4.3b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Exelixis

Market Cap: US$11.7b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Biogen

Market Cap: US$26.1b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

ACADIA Pharmaceuticals

Market Cap: US$4.4b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Vaxcyte

Market Cap: US$6.1b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Corcept Therapeutics

Market Cap: US$4.0b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Regeneron Pharmaceuticals

Market Cap: US$79.6b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Catalyst Pharmaceuticals

Market Cap: US$2.8b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

Wave Life Sciences

Market Cap: US$2.9b

A clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.

IDEAYA Biosciences

Market Cap: US$3.0b

A precision medicine oncology company, discovers and develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States.

United Therapeutics

Market Cap: US$21.4b

A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Structure Therapeutics

Market Cap: US$4.7b

A clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States.

Beam Therapeutics

Market Cap: US$2.7b

A biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States.

Kiniksa Pharmaceuticals International

Market Cap: US$3.2b

A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.

Viridian Therapeutics

Market Cap: US$2.9b

Engages in discovering, developing, and commercializing treatments for serious and rare diseases.

Bio-Techne

Market Cap: US$9.3b

Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.

Supernus Pharmaceuticals

Market Cap: US$2.8b

A biopharmaceutical company, develops and commercializes products for the treatment of central nervous system (CNS) diseases in the United States.

Neurocrine Biosciences

Market Cap: US$14.0b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

Xenon Pharmaceuticals

Market Cap: US$3.4b

A neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada.

Apogee Therapeutics

Market Cap: US$5.1b

A clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other inflammatory and immunology indications.

Spyre Therapeutics

Market Cap: US$2.4b

A clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD).

Incyte

Market Cap: US$19.9b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

GRAIL

Market Cap: US$3.5b

A commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.

Terns Pharmaceuticals

Market Cap: US$4.4b

A clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity.

Praxis Precision Medicines

Market Cap: US$7.2b

A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance.

Summit Therapeutics

Market Cap: US$13.5b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

Viking Therapeutics

Market Cap: US$4.0b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

Denali Therapeutics

Market Cap: US$2.5b

A biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases.

Harmony Biosciences Holdings

Market Cap: US$2.2b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.

Immunome

Market Cap: US$2.3b

A clinical-stage biotechnology company, develops targeted cancer therapies.

Roivant Sciences

Market Cap: US$15.3b

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.

Krystal Biotech

Market Cap: US$7.2b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Vertex Pharmaceuticals

Market Cap: US$114.7b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

Veracyte

Market Cap: US$3.4b

Operates as a diagnostics company in the United States and internationally.

West Pharmaceutical Services

Market Cap: US$19.9b

Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.